Date | Price Target | Rating | Analyst |
---|---|---|---|
1/5/2024 | $14.00 → $18.00 | Equal-Weight → Overweight | Stephens |
2/27/2023 | $15.00 → $16.00 | Hold → Buy | Stifel |
8/25/2022 | $22.00 | Outperform | Oppenheimer |
6/21/2022 | $23.00 → $17.00 | Overweight → Equal-Weight | Stephens |
3/10/2022 | $37.00 → $26.00 | Outperform | RBC Capital |
3/2/2022 | $33.00 → $26.00 | Overweight | Stephens & Co. |
3/1/2022 | $32.00 → $18.00 | Buy → Hold | Stifel |
11/10/2021 | $44.00 → $37.00 | Outperform | RBC Capital |
EAGLE, Idaho, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the second quarter of 2024, reporting GAAP diluted earnings per share of $0.18 for the second quarter of 2024. Pennant also reported adjusted diluted earnings per share of $0.24 for the quarter (1). Second Quarter Highlights Total revenue for the second quarter was $168.7 million, an increase of $36.5 million or 27.6% over the prior year quarter; Net income for the second quarter was $5.7 million, an increase of $2.9 million or 103.4% over
EAGLE, Idaho, May 16, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced that it has acquired Nurses on Wheels, Inc. ("Nurses on Wheels"), which provides hospice services in Corpus Christi, Texas and the surrounding communities. "We are excited to expand the reach of our hospice operations in south Texas," said Brent Guerisoli, Chief Executive Officer of Pennant. "Our strategy of empowering local leaders to meet the needs of local communities has resonated deeply across our platform and we look forward to bringing our innovative operating model an
EAGLE, Idaho, May 06, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the first quarter of 2024, reporting GAAP diluted earnings per share of $0.16 for the first quarter of 2024. Pennant also reported adjusted diluted earnings per share of $0.20 for the quarter (1). First Quarter Highlights Total revenue for the quarter was $156.9 million, an increase of $30.5 million or 24.1% over the prior year quarter; Net income for the first quarter was $4.9 million, an increase of $3.1 million or 165.2%
EAGLE, Idaho, May 22, 2023 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that its Board of Directors has appointed Lynette Walbom as Chief Financial Officer effective May 22, 2023. Before joining Pennant, Ms. Walbom was Vice President of Financial Reporting & Tax for Raising Cane's Restaurants, LLC, a national restaurant chain operating in 35 states, which more than doubled in size—based on number of restaurants and geographic footprint—during her tenure. At Raising Cane's, Ms. Walbom had broad responsibility for financial reporting, acquisitions, tax, accou
EAGLE, Idaho, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced the appointment of Barry Smith as Chairman of its board of directors and Brent Guerisoli as a member of its board of directors. Mr. Smith has served on Pennant's board since 2021. He previously served as Chairman and CEO of Magellan Health, Inc., the nation's largest provider of behavioral health services and a leading provider of pharmacy benefit management services, from 2013 to 2019, and as Chairman, President and CEO of VistaCare, a national hospice provider, from 1996 to 2002. "Ba
EAGLE, Idaho, June 07, 2022 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that its Board of Directors has appointed Brent Guerisoli, current President of Pennant, to succeed Daniel Walker as Chief Executive Officer of Pennant, effective August 1, 2022. Mr. Walker will continue to serve as chairman of Pennant's Board of Directors. Commenting on this announcement, Walker said, "After careful reflection, I have made the decision to reduce my professional obligations in consideration of family circumstances, to pursue charitable causes unrelated to Pennant or
S-3ASR - Pennant Group, Inc. (0001766400) (Filer)
10-Q - Pennant Group, Inc. (0001766400) (Filer)
8-K - Pennant Group, Inc. (0001766400) (Filer)
4 - Pennant Group, Inc. (0001766400) (Issuer)
4 - Pennant Group, Inc. (0001766400) (Issuer)
4 - Pennant Group, Inc. (0001766400) (Issuer)
Stephens upgraded Pennant Group from Equal-Weight to Overweight and set a new price target of $18.00 from $14.00 previously
Stifel upgraded Pennant Group from Hold to Buy and set a new price target of $16.00 from $15.00 previously
Oppenheimer initiated coverage of Pennant Group with a rating of Outperform and set a new price target of $22.00
EAGLE, Idaho, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the second quarter of 2024, reporting GAAP diluted earnings per share of $0.18 for the second quarter of 2024. Pennant also reported adjusted diluted earnings per share of $0.24 for the quarter (1). Second Quarter Highlights Total revenue for the second quarter was $168.7 million, an increase of $36.5 million or 27.6% over the prior year quarter; Net income for the second quarter was $5.7 million, an increase of $2.9 million or 103.4% over
EAGLE, Idaho, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it has completed its purchase of the Washington and Idaho assets of Signature Healthcare at Home. Pennant previously announced its agreement to purchase the Signature assets, with the planned closing of Signature's Washington and Idaho assets on August 1, and a second purchase agreement capturing Signature's Oregon business closing on January 1, 2025. Today's acquisition will add to Pennant's existing strength in Idaho, and build out Pennant's Washington footprint in a critical c
EAGLE, Idaho, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that the Company has increased its credit facility by $100 million to an aggregate of $250 million. The borrowings are supported by a lending consortium arranged by Truist Securities. The new facility expires on July 31, 2029. "This amended facility further strengthens our balance sheet, and together with our strong operating cash flow, creates significant dry powder for future growth," said Brent Guerisoli, Pennant's Chief Executive Officer. "As always, we will be disciplined and prud
SC 13G - Pennant Group, Inc. (0001766400) (Subject)
SC 13G/A - Pennant Group, Inc. (0001766400) (Subject)
SC 13G/A - Pennant Group, Inc. (0001766400) (Subject)
Pennant Gr (NASDAQ:PNTG) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 3 2 0 0 Last 30D 0 0 1 0 0 1M Ago 0 1 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 2 1 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $25.4, along with a high estimate of $28.00 and a low estimate of $23.00. This upward trend
Truist Securities analyst David Macdonald maintains Pennant Gr (NASDAQ:PNTG) with a Hold and raises the price target from $25 to $28.
- Reuters